Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Heather L. Gornik, MD, MHS, Director Noninvasive Vascular Laboratory Cleveland Clinic, discusses the treatment of FMD or fibromuscular dysplasia, which depends on the vascular beds involved and the…
NEW YORK (Reuters Health) – Even though they are at increased risk of invasive cervical cancer, nearly one in four HIV-positive women in the US who were recently…
NEW YORK (Reuters Health) – In general, bariatric surgery is associated with a low risk of death and other adverse events in the 30-day postoperative period, according to…
NEW YORK (Reuters Health) – Upon starting an antipsychotic drugs, older patients with diabetes are prone to episodes of hyperglycemia severe enough to require hospitalization, Canadian researchers report…
NEW YORK (Reuters Health) – Nearly one out of six patients in China who is prescribed an antihypertensive agent will discontinue treatment within 6 months. Multiple factors affect…
NEW YORK (Reuters Health) – In patients with metastatic renal cell carcinoma, first-line treatment with interferon (IFN)-alpha plus sunitinib or bevacizumab has “clinically relevant and statistically significant” survival…
NEW YORK (Reuters Health) – The results of a 30-year study indicate that intensive glucose control can substantially reduce the rates of retinopathy, nephropathy, and cardiovascular disease in…
NEW YORK (Reuters Health) – In patients with pulmonary thromboemboli, the presence of a mobile right cardiac thrombus (MRCT) is strongly linked to death, new research shows. Although…
NEW YORK (Reuters Health) – Sterile water injected lateral to the lumbosacral spine in women with severe low back pain during labor substantially reduces pain and decreases the…
NEW YORK (Reuters Health) – Adding hormone therapy to radiotherapy for locally advanced prostate cancer reduces disease recurrence and prolongs survival, according to a report in the August…
